Caption Management, LLC Black Diamond Therapeutics, Inc. Transaction History
Caption Management, LLC
- $9.8 Billion
- Q4 2024
A detailed history of Caption Management, LLC transactions in Black Diamond Therapeutics, Inc. stock. As of the latest transaction made, Caption Management, LLC holds 126,100 shares of BDTX stock, worth $176,540. This represents 0.01% of its overall portfolio holdings.
Number of Shares
126,100Holding current value
$176,540% of portfolio
0.01%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding BDTX
# of Institutions
93Shares Held
47.4MCall Options Held
2.9KPut Options Held
69.4K-
T. Rowe Price Investment Management, Inc. Baltimore, MD10.5MShares$14.7 Million0.01% of portfolio
-
Bellevue Group Ag Kuesnacht, V88.52MShares$11.9 Million0.36% of portfolio
-
Vestal Point Capital, LP New York, NY5.6MShares$7.84 Million0.71% of portfolio
-
Nea Management Company, LLC Timonium, MD4.45MShares$6.23 Million0.68% of portfolio
-
Black Rock Inc. New York, NY3.22MShares$4.5 Million0.0% of portfolio
About Black Diamond Therapeutics, Inc.
- Ticker BDTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,339,500
- Market Cap $50.9M
- Description
- Black Diamond Therapeutics, Inc., a biotechnology company, discover, develops, and commercializes medicines for patient with genetically defined tumors. It develops BDTX-189, an irreversible small molecule inhibitor that is designed to targets oncogenic proteins defined by the non-canonical epidermal growth factor receptor (EGFR) and human epide...